Home > Healthcare > Medical Devices > Implantable Devices > Annuloplasty System Market

Annuloplasty System Market Share

Report ID: GMI9243
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Annuloplasty System Market Share

The annuloplasty system industry is characterized by the presence of several established and emerging players that offer a variety of products and services across the globe. The market players compete based on factors such as product quality, innovation, regulatory compliance, customer service, and pricing strategies.

Annuloplasty system Market Companies

Prominent players operating in the annuloplasty system industry include:

Abbott Laboratories
Affluent Medical
BioStable Science & Engineering
Corcym UK Limited
Coroneo
Edwards Lifesciences Corporation
Genesee BioMedical
Medtentia International Ltd Oy
Medtronic plc
Micro Interventional Devices Incorporated

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Annuloplasty system market size was USD 473.9 million in 2023 and will grow at an 8.2% CAGR between 2024 and 2032, propelled by rising prevalence of valvular heart diseases, advancements in minimally invasive surgical techniques, and aging populationsworldwide.

The mitral valve repair application segment recorded USD 240.8 million in 2023 due to their ability to preserve valve function and mitigate risks associated with prosthetic devices.

North America annuloplasty system industry recorded USD 198.5 million in 2023 and will expand at 7.8% CAGR till 2032, owing to advanced healthcare infrastructure, high prevalence rates of cardiovascular diseases, and extensive adoption of innovative medical technologies.

Abbott Laboratories, Affluent Medical, BioStable Science & Engineering, Corcym UK Limited, Coroneo, Edwards Lifesciences Corporation, Genesee BioMedical, Medtentia International Ltd Oy, Medtronic plc, and Micro Interventional Devices Incorporated among others.